Trump’s FDA pick Heidi Overton dropped as Republicans dispute her Senate support
The White House dropped President Donald Trump’s nominee to lead the US Food and Drug Administration on 17 November, leaving the agency under acting leadership as Republicans dispute whether she could have won Senate confirmation.

Senior health officials were caught off guard by the decision to abandon Dr Heidi Overton’s nomination, CNN reported, citing people familiar with the matter. Two sources told the network that members of her team learned of the decision from an Axios report. Two also said it angered Senator Bill Cassidy, the Republican chair of the Senate health committee.
A senior administration official told Axios that Overton lacked the congressional support needed to advance. Cassidy, however, said he believed she had the votes to pass both his committee and the full Senate.
The committee had scheduled a vote for 18 November, but removed Overton from its agenda and did not vote on her nomination.
CNN reported that Overton’s team had made commitments to Republican Senator Josh Hawley that officials hoped would secure a crucial committee vote. Hawley told reporters the next day that her responses were “completely responsive to everything I asked for”. The commitments concerned an FDA study of the abortion pill mifepristone, including publishing its expected completion date.
CBS News reported, citing two people familiar with the matter, that efforts to gather enough Republican votes were still under way when the decision was shared. Neither a committee nor a full Senate vote took place to establish whether Overton would have been confirmed.
Cassidy also said senators opposed to abortion had sought further assurances from the administration on abortion issues and that the White House withdrew Overton rather than make those commitments.
CNN also reported that Overton’s allies believe the White House used uncertainty over Senate support to justify dropping a nominee whom Health Secretary Robert F. Kennedy Jr and new White House chief of staff Stephen Miller had soured on. White House and health department spokespeople did not respond to CNN’s requests for comment on its account.
Overton, a physician and White House domestic policy official, was nominated in August. Her positions on vaccines and abortion had drawn criticism during the confirmation process.
Kyle Diamantas has served as acting commissioner since May. Cassidy said the limited time remaining meant confirmation of a permanent FDA chief would fall to Senate Democrats. The Associated Press reports that Democrats will hold a 56–44 Senate majority when the new Congress begins in January.
Sign in to give this article a thumbs up or down.
From the discussion
Private test discussion. Comments are readers’ views and are not yet automatically fact-checked. Editing is available for 60 seconds after posting.
Sign in with a confirmed reader account and choose a username to read comments and participate.
Sorting applies to top-level comments; replies remain oldest first. New comments and likes can change the order. Refresh for the current ranking.
Loading comments…